Drugs / T89
T89
Trials 9
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT01679028 | Aug → Oct 2012 | — | Tasly Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01473888 | Jan → Jul 2011 | intermediate coronary syndrome | Tasly Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT03552263 | Jun 2018 → Oct 2019 | acute mountain sickness | Tasly Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00797953 | Feb 2007 → Dec 2009 | coronary artery disorder | Tasly Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT04993729 | Jul 2021 → May 2023 | acute mountain sickness | Tasly Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT03789552 | Aug 2019 → Dec 2026 expected | intermediate coronary syndrome | Tasly Pharmaceuticals, Inc. | Recruiting | No outcome recorded |
| Phase 3 | NCT01659580 | Aug 2012 → Dec 2016 | — | Tasly Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT04285190 | Feb → Apr 2020 | COVID-19 | Tasly Pharmaceuticals, Inc. | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase not stated1 trial | ||||||
| — | NCT04646031 | — | COVID-19 | Tasly Pharmaceuticals, Inc. | No longer available | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | T89 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04285190 ↗ |
| Known as | Dantonic | “T89 capsule (trade name Dantonic®) is a botanical drug containing 75mg active substance which is the water extract of Danshen and Sanqi.” NCT04993729 ↗1“Drug: T89(Dantonic)” NCT01473888 ↗ |
| Known as | T89 capsule | “T89 capsule is a botanical drug containing 75mg active substance which is the water extract of Danshen and Sanqi.” NCT03789552 ↗1“T89 capsule is a botanical drug containing 75mg active substance which is the water extract of Danshen and Sanqi.” NCT03552263 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “T89 is a modernized and industrialized version of a traditional Chinese herbal medicine.” NCT00797953 ↗ |
| Route | Oral | “A two-herb botanical drug product in 62.5mg capsule formulation. It is to be used as 125mg or 187.5mg twice daily.” NCT00797953 ↗ |